Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Loda

Showing results (231-240 of 409) with videos related to

Pageof 41
Sort By:
European Urology|July 7, 2020
Inferior Cancer Survival for Men with Localized High-grade Prostate Cancer but Low Prostate-specific AntigenChristian D Fankhauser, Kathryn L Penney, Amparo G Gonzalez-Feliciano, et al.
Cancer Research|April 24, 2013
Animal models of human prostate cancer: the consensus report of the New York meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology CommitteeMichael Ittmann, Jiaoti Huang, Enrico Radaelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2009
Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?Jennifer R Stark, Sven Perner, Meir J Stampfer, et al.
JCO Precision Oncology|October 5, 2020
Systematic Assessment of Tumor Purity and Its Clinical ImplicationsSyed Haider, Svitlana Tyekucheva, Davide Prandi, et al.
Nature Medicine|May 25, 2004
mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathwaysPradip K Majumder, Phillip G Febbo, Rachel Bikoff, et al.
The Journal of Molecular Diagnostics : JMD|August 11, 2007
DNA degradation test predicts success in whole-genome amplification from diverse clinical samplesFengfei Wang, Lilin Wang, Christine Briggs, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 1, 2011
Common polymorphisms in the adiponectin and its receptor genes, adiponectin levels and the risk of prostate cancerPreet K Dhillon, Kathryn L Penney, Fredrick Schumacher, et al.
Elife|December 23, 2021
Extent, impact, and mitigation of batch effects in tumor biomarker studies using tissue microarraysKonrad H Stopsack, Svitlana Tyekucheva, Molin Wang, et al.
Molecular Cancer Research : MCR|July 3, 2020
Inhibition of O-GlcNAc Transferase Renders Prostate Cancer Cells Dependent on CDK9Harri M Itkonen, Ninu Poulose, Rebecca E Steele, et al.
The Journal of Clinical Investigation|February 22, 2013
ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancerChangmeng Cai, Hongyun Wang, Housheng Hansen He, et al.
Pageof 41

Showing results (231-240 of 409) with videos related to

Sort By:
Pageof 41
European Urology|July 7, 2020
Inferior Cancer Survival for Men with Localized High-grade Prostate Cancer but Low Prostate-specific AntigenChristian D Fankhauser, Kathryn L Penney, Amparo G Gonzalez-Feliciano, et al.
Cancer Research|April 24, 2013
Animal models of human prostate cancer: the consensus report of the New York meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology CommitteeMichael Ittmann, Jiaoti Huang, Enrico Radaelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2009
Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?Jennifer R Stark, Sven Perner, Meir J Stampfer, et al.
JCO Precision Oncology|October 5, 2020
Systematic Assessment of Tumor Purity and Its Clinical ImplicationsSyed Haider, Svitlana Tyekucheva, Davide Prandi, et al.
Nature Medicine|May 25, 2004
mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathwaysPradip K Majumder, Phillip G Febbo, Rachel Bikoff, et al.
The Journal of Molecular Diagnostics : JMD|August 11, 2007
DNA degradation test predicts success in whole-genome amplification from diverse clinical samplesFengfei Wang, Lilin Wang, Christine Briggs, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 1, 2011
Common polymorphisms in the adiponectin and its receptor genes, adiponectin levels and the risk of prostate cancerPreet K Dhillon, Kathryn L Penney, Fredrick Schumacher, et al.
Elife|December 23, 2021
Extent, impact, and mitigation of batch effects in tumor biomarker studies using tissue microarraysKonrad H Stopsack, Svitlana Tyekucheva, Molin Wang, et al.
Molecular Cancer Research : MCR|July 3, 2020
Inhibition of O-GlcNAc Transferase Renders Prostate Cancer Cells Dependent on CDK9Harri M Itkonen, Ninu Poulose, Rebecca E Steele, et al.
The Journal of Clinical Investigation|February 22, 2013
ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancerChangmeng Cai, Hongyun Wang, Housheng Hansen He, et al.
Pageof 41